Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in TMO — Thermo Fisher Scientific Inc.

CIK 886982 NEW YORK, NY
Back to TMO Full portfolio

Position in TMO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,482,554,608
-$69,316,685 QoQ
Shares Held
2,957,066
-6.3% QoQ
Ownership
0.800%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#22
of 2,606 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 89% Shared 0% None 10%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Derivatives in TMO

reported options exposure · as of Jun 30, 2026
CallValue
$47,528,928
CallShares
94,800
PutValue
$22,059,840
PutShares
44,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $7,203,937,912 across 33 Diagnostics & Research names. TMO ranks #1 (20.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
This page 		2,957,066 $1,482,554,608
2 DHR
Danaher Corp /De/
 5,364,861 $1,021,898,721
3 A
Agilent Technologies, Inc.
 4,707,720 $625,326,445
4 GH
Guardant Health, Inc.
 3,775,895 $566,497,524
5 NTRA
Natera, Inc.
 1,720,152 $466,935,259
6 IDXX
Idexx Laboratories Inc /De
 738,708 $388,885,438
7 IQV
Iqvia Holdings Inc.
 1,949,797 $376,739,772
8 MTD
Mettler Toledo International Inc/
 252,137 $322,107,537

All Filings in TMO

Export CSV
44 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,482,554,608 2,957,066
2026-06-30 $47,528,928 94,800
2026-06-30 $22,059,840 44,000
2026-03-31 $36,618,985 74,500
2026-03-31 $16,859,479 34,300
2026-03-31 $1,551,871,293 3,157,226
2025-09-30 $9,166,878 18,900
2025-09-30 $1,258,993,573 2,595,756
2025-09-30 $242,510 500
2025-06-30 $1,054,196 2,600
2025-06-30 $851,466 2,100
2025-06-30 $941,270,927 2,321,489
2024-12-31 $1,146,266,975 2,203,385
2024-12-31 $2,861,265 5,500
2024-12-31 $2,341,035 4,500
2024-09-30 $1,523,477,906 2,462,903
2024-09-30 $2,783,565 4,500
2024-09-30 $8,969,265 14,500
2024-06-30 $1,330,765,744 2,406,448
2024-06-30 $3,318,000 6,000
2024-06-30 $3,318,000 6,000
2024-03-31 $7,032,641 12,100
2024-03-31 $7,207,004 12,400
2024-03-31 $1,137,214,082 1,956,632
2022-03-31 $16,715,395 28,300
2022-03-31 $14,529,990 24,600
2022-03-31 $823,136,925 1,393,612
2021-06-30 $707,714,401 1,402,887
2021-06-30 $7,617,497 15,100
2021-06-30 $8,424,649 16,700
2021-03-31 $7,119,528 15,600
2021-03-31 $8,534,306 18,700
2021-03-31 $700,572,505 1,535,064
2020-12-31 $11,318,454 24,300
2020-12-31 $710,995,002 1,526,461
2020-12-31 $24,313,716 52,200
2020-09-30 $6,578,648 14,900
2020-09-30 $511,470,893 1,158,432
2020-09-30 $10,419,872 23,600
2020-06-30 $555,144,733 1,532,110
2020-06-30 $9,130,968 25,200
2020-06-30 $1,195,722 3,300
2020-03-31 $10,663,360 37,600
2020-03-31 $499,168,043 1,760,113

Report a Problem

Category
Description
Email (optional, for follow-up)